Skip to main content
×
Home
    • Aa
    • Aa
  • Access
  • Cited by 12
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Huang, Mei-Chiung Jo and Tang, Jane 2015. Probiotics in personal care products. Microbiology Discovery, Vol. 3, Issue. 1, p. 5.


    Clemente, Alfonso 2014. Food Oligosaccharides.


    Foligné, Benoit Daniel, Catherine and Pot, Bruno 2013. Probiotics from research to market: the possibilities, risks and challenges. Current Opinion in Microbiology, Vol. 16, Issue. 3, p. 284.


    O'Connor, E. M. 2013. Clinical trials for foods and supplements: Guidance for industry symposium report. Nutrition Bulletin, Vol. 38, Issue. 2, p. 262.


    Kongo, J.M. and Malcata, F.X. 2016. Encyclopedia of Food and Health.


    Caffarelli, Carlo Cardinale, Fabio Povesi-Dascola, Carlotta Dodi, Icilio Mastrorilli, Violetta and Ricci, Giampaolo 2015. Use of probiotics in pediatric infectious diseases. Expert Review of Anti-infective Therapy, Vol. 13, Issue. 12, p. 1517.


    Gibson, Glenn R. Brummer, Robert J. Isolauri, Erika Lochs, Herbert Morelli, Lorenzo Ockhuizen, Theo Rowland, Ian R. Schrezenmeir, Jürgen Stanton, Catherine and Verbeke, Kristin 2011. The design of probiotic studies to substantiate health claims.. Gut Microbes, Vol. 2, Issue. 5, p. 299.


    Ringel, Yehuda Quigley, Eamonn MM and Lin, Henry C 2012. Using Probiotics in Gastrointestinal Disorders. The American Journal of Gastroenterology Supplements, Vol. 1, Issue. 1, p. 34.


    Marsh, Alan J. Hill, Colin Ross, R. Paul and Cotter, Paul D. 2014. Fermented beverages with health-promoting potential: Past and future perspectives. Trends in Food Science & Technology, Vol. 38, Issue. 2, p. 113.


    Glanville, Julie King, Sarah Guarner, Francisco Hill, Colin and Sanders, Mary 2015. A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union. Nutrition Journal, Vol. 14, Issue. 1, p. 16.


    van den Nieuwboer, M. van de Burgwal, L.H.M. and Claassen, E. 2016. A quantitative key-opinion-leader analysis of innovation barriers in probiotic research and development: Valorisation and improving the tech transfer cycle. PharmaNutrition, Vol. 4, Issue. 1, p. 9.


    Clarke, G. Cryan, J. F. Dinan, T. G. and Quigley, E. M. 2012. Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria. Alimentary Pharmacology & Therapeutics, Vol. 35, Issue. 4, p. 403.


    ×

Probiotic and prebiotic claims in Europe: seeking a clear roadmap

  • Francisco Guarner (a1), Mary Ellen Sanders (a2), Glenn Gibson (a3), Todd Klaenhammer (a4), Michael Cabana (a5), Karen Scott (a6), Gregor Reid (a7), Nathalie M. Delzenne (a8), George C. Fahey (a9) and Colin Hill (a10)
  • DOI: http://dx.doi.org/10.1017/S0007114511002248
  • Published online: 21 June 2011
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Probiotic and prebiotic claims in Europe: seeking a clear roadmap
      Your Kindle email address
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Probiotic and prebiotic claims in Europe: seeking a clear roadmap
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Probiotic and prebiotic claims in Europe: seeking a clear roadmap
      Available formats
      ×
Abstract
Copyright
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2M Hickson , AL D'Souza , N Muthu , (2007) Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335, 80.

3EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010) Scientific opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) no. 1924/2006. EFSA J 8, 1903. www.efsa.europa.eu/efsajournal.htm.

4L Kyne , MB Hamel , R Polavaram , (2002) Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 34, 346353.

5MH Wilcox , JG Cunniffe , C Trundle , (1996) Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 34, 2330.

6EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010) Scientific opinion on the substantiation of health claims related to lactulose and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 806) and reduction in intestinal transit time (ID 807) pursuant to Article 13(1) of Regulation (EC) no. 1924/2006. EFSA J 8, 1806.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×